The Effect of Intravenous and Oral Fluconazole on the Pharmacokinetics and Pharmacodynamics of Intravenous Alfentanil
Authors:
- Mika H. IsohanniMIMika H. Isohanni
- Pertti J. NeuvonenPNPertti J. Neuvonen
- Klaus T. OlkkolaKOKlaus T. Olkkola
- 1 July 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 87 (1) , 190-194
Abstract
The azole antimycotic fluconazole inhibits cytochrome P450 enzymes. We studied the possible interaction of alfentanil with oral and i.v. fluconazole in a three-phase, double-blind, placebo-controlled, randomized, cross-over study at intervals of 4 wk. Nine healthy volunteers were given a single oral dose of either fluconazole 400 mg or placebo, followed within 60 min by either i.v. fluconazole 400 mg in saline or saline only. The dose of 20 micrograms/kg of alfentanil was given i.v. 1 h after the fluconazole/placebo. Venous plasma samples were collected, and pharmacodynamic measurements were performed for 10 h. Alfentanil clearance was decreased from 3.1 +/- 1.1 mL.min-1.kg-1 to 1.3 +/- 0.3 mL.min-1. kg-1 after i.v. fluconazole and to 1.4 +/- 0.4 mL.min-1. kg-1 after oral fluconazole (P < 0.001). The mean elimination half-life of alfentanil was almost doubled after both oral and i.v. fluconazole (P < 0.001). Fluconazole increased the subjective effects of alfentanil as quantified on visual analog scales (P < 0.01). Correspondingly, both i.v. and oral fluconazole also increased the alfentanil-induced respiratory depression by decreasing the respiratory rate by 10%-15% (P < 0.05). We conclude that metabolism of alfentanil is inhibited by oral and i.v. fluconazole and that caution should be exercised when alfentanil is given to patients receiving fluconazole. We studied the interaction of cytochrome P450 3A4 enzyme inhibitor fluconazole with alfentanil. Nine volunteers were given placebo or fluconazole 400 mg orally or i.v. Alfentanil 20 micrograms/kg was given i.v. 1 h after pretreatment. Fluconazole decreased the clearance of alfentanil by 55% and increased the alfentanil-induced subjective effects.Keywords
This publication has 15 references indexed in Scilit:
- The Role of Cytochrome P450 3A4 in Alfentanil ClearanceAnesthesiology, 1997
- Effect of route of administration of fluconazole on the interaction between fluconazole and midazolamEuropean Journal of Clinical Pharmacology, 1997
- Identification of the Pharmacogenetic Determinants of Alfentanil MetabolismAnesthesiology, 1992
- Determination of Fluconazole in Human Serum by Solid-Phase Extraction and Reversed-Phase High-Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1992
- Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.British Journal of Clinical Pharmacology, 1991
- Inhibition of alfentanil metabolism by erythromycinClinical Pharmacology & Therapeutics, 1989
- Inspiratory end-tidal oxygen content differenceCritical Care Medicine, 1989
- Alfentanil Pharmacokinetics and Metabolism in HumansAnesthesiology, 1988
- Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Preliminary pharmacokinetic profile in manJournal of Pharmacy and Pharmacology, 1983
- A Simplified Entoptic PupillometerAmerican Journal of Ophthalmology, 1941